SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?


To: scaram(o)uche who wrote (3371)4/8/2001 9:04:03 AM
From: tom pope  Read Replies (1) | Respond to of 52153
 
Barron's has a piece on the cash position of selected biotechs - I have the print version only so can't cut and paste - listing companies with high cash ratios.
Didn't mention INCY or AFFX for some reason.



To: scaram(o)uche who wrote (3371)4/8/2001 1:37:22 PM
From: johnsto1  Respond to of 52153
 
Richard,
What's your opinion on Radio Frequency as a viable cure for skin cancer-replacing the 50 yr old MOH's treatment?
Radio Frequencies; do you think using radio frequency to create heat within the diseased tissue is a viable treatment for skin cancers. No cutting involved; NASA among others, working with radio frequency for internal cancers using internal probes(cervical,prostate,etc).
The concept is hypothermia has been a viable treatment along with radiation for cancer tumors(studies have shown-raising the cure rate from 25% to 65% when added)the problem was the hypothermia would heat the entire body above blood temp causing irreparable damage. Now some companies have the ability to pin point the accuracy of the heat to destroy the diseased tissue leaving the healthy tissue undamaged.

Thanks